ALT5 Sigma Corp: Funding, Investors & Team (Sep 2026)
JanOne is focused on developing treatments for diseases that cause severe pain. By alleviating pain at the source, JanOne aims to reduce the need for opioid prescriptions to treat disease associated pain that can lead to opioid abuse. The company is also exploring solutions for non-addictive pain medications. Its lead candidate JAN101 is for treating peripheral artery disease (PAD), a condition that affects over 8.5 million Americans. JAN101 demonstrated positive results in a Phase 2a clinical trial, and Phase 2b trials are expected to begin in early 2021.
ALT5 Sigma Corp has raised $1.5B across 2 funding rounds on record, the most recent an undisclosed round of $1.5B announced in Aug 2025.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
ALT5 Sigma Corp Company Profile and Key Stats
Latest funding round on record: Aug 2025.
ALT5 Sigma Corp Funding Rounds
ALT5 Sigma Corp raised $790k in an undisclosed round announced in Aug 2023.
2 years later, an undisclosed round of $1.5B was announced in Aug 2025.
ALT5 Sigma Corp Founders and Leadership Team
No contact details are on record for this team yet.
ALT5 Sigma Corp Funding Compared to Other Biotechnology Startups
ALT5 Sigma Corp's latest round of $1.5B is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like ALT5 Sigma Corp in Biotechnology and Minneapolis
Companies Similar to ALT5 Sigma Corp
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
ALT5 Sigma Corp Funding FAQs
What does ALT5 Sigma Corp do?
JanOne is focused on developing treatments for diseases that cause severe pain. By alleviating pain at the source, JanOne aims to reduce the need for opioid prescriptions to treat disease associated pain that can lead to opioid abuse. The company is also exploring solutions for non-addictive pain medications. Its lead candidate JAN101 is for treating peripheral artery disease (PAD), a condition that affects over 8.5 million Americans. JAN101 demonstrated positive results in a Phase 2a clinical trial, and Phase 2b trials are expected to begin in early 2021.
How much funding has ALT5 Sigma Corp raised?
ALT5 Sigma Corp has raised $1.5B across 2 rounds on record. The most recent is an undisclosed round of $1.5B announced in Aug 2025.
When did ALT5 Sigma Corp last raise funding?
ALT5 Sigma Corp's most recent funding round on record is an undisclosed round of $1.5B, announced in Aug 2025.
Who founded ALT5 Sigma Corp?
FundedIQ lists Jack Cameron (Founder) at ALT5 Sigma Corp.
Where is ALT5 Sigma Corp headquartered?
ALT5 Sigma Corp is based in Minneapolis, Minnesota, United States.
How many employees does ALT5 Sigma Corp have?
ALT5 Sigma Corp is in the 11-50 employee band.
How does ALT5 Sigma Corp's funding compare to other Biotechnology startups?
ALT5 Sigma Corp's latest round of $1.5B is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's ALT5 Sigma Corp Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for ALT5 Sigma Corp is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.